- Home
- ARQT vs IAS Comparison
ARQT vs IAS Comparison
Compare ARQT & IAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- IAS
- Stock Information
- Founded
- ARQT 2016
- IAS 2009
- Country
- ARQT United States
- IAS United States
- Employees
- ARQT N/A
- IAS N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- IAS Computer Software: Programming Data Processing
- Sector
- ARQT Health Care
- IAS Technology
- Exchange
- ARQT Nasdaq
- IAS Nasdaq
- Market Cap
- ARQT 2.1B
- IAS 1.7B
- IPO Year
- ARQT 2020
- IAS 2021
- Fundamental
- Price
- ARQT $24.38
- IAS $10.23
- Analyst Decision
- ARQT Strong Buy
- IAS Buy
- Analyst Count
- ARQT 7
- IAS 11
- Target Price
- ARQT $22.17
- IAS $13.57
- AVG Volume (30 Days)
- ARQT 2.5M
- IAS 1.6M
- Earning Date
- ARQT 10-28-2025
- IAS 11-04-2025
- Dividend Yield
- ARQT N/A
- IAS N/A
- EPS Growth
- ARQT N/A
- IAS 42.72
- EPS
- ARQT N/A
- IAS 0.28
- Revenue
- ARQT $317,929,000.00
- IAS $590,666,000.00
- Revenue This Year
- ARQT $85.27
- IAS $14.72
- Revenue Next Year
- ARQT $30.70
- IAS $11.34
- P/E Ratio
- ARQT N/A
- IAS $36.62
- Revenue Growth
- ARQT 129.21
- IAS 15.51
- 52 Week Low
- ARQT $8.45
- IAS $6.26
- 52 Week High
- ARQT $27.08
- IAS $13.62
- Technical
- Relative Strength Index (RSI)
- ARQT 64.85
- IAS 68.53
- Support Level
- ARQT $19.60
- IAS $10.21
- Resistance Level
- ARQT $27.08
- IAS $10.23
- Average True Range (ATR)
- ARQT 1.25
- IAS 0.02
- MACD
- ARQT 0.21
- IAS -0.04
- Stochastic Oscillator
- ARQT 63.91
- IAS 57.14
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About IAS Integral Ad Science Holding Corp.
Integral Ad Science Holding Corp is a digital advertising verification company. The cloud-based technology platform of the company delivers independent measurement and verification of digital advertising across all devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video. Geographically, the company derives a majority of its revenue from the Americas region.